25 XP   0   0   10

Ventyx Biosciences Inc
Buy, Hold or Sell?

Let's analyse Ventyx Biosciences Inc together

PenkeI guess you are interested in Ventyx Biosciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Ventyx Biosciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Ventyx Biosciences Inc

I send you an email if I find something interesting about Ventyx Biosciences Inc.

Quick analysis of Ventyx Biosciences Inc (30 sec.)










What can you expect buying and holding a share of Ventyx Biosciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$3.46
Expected worth in 1 year
$1.90
How sure are you?
23.1%

+ What do you gain per year?

Total Gains per Share
$-1.56
Return On Investment
-34.9%

For what price can you sell your share?

Current Price per Share
$4.47
Expected price per share
$1.865 - $11.48
How sure are you?
50%

1. Valuation of Ventyx Biosciences Inc (5 min.)




Live pricePrice per Share (EOD)

$4.47

Intrinsic Value Per Share

$-43.91 - $-52.27

Total Value Per Share

$-40.45 - $-48.81

2. Growth of Ventyx Biosciences Inc (5 min.)




Is Ventyx Biosciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$243.9m$309.9m-$3.1m-1.0%

How much money is Ventyx Biosciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$47.3m-$26.7m-$20.6m-43.5%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Ventyx Biosciences Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#213 / 1016

Most Revenue
#822 / 1016

Most Profit
#885 / 1016

Most Efficient
#267 / 1016

What can you expect buying and holding a share of Ventyx Biosciences Inc? (5 min.)

Welcome investor! Ventyx Biosciences Inc's management wants to use your money to grow the business. In return you get a share of Ventyx Biosciences Inc.

What can you expect buying and holding a share of Ventyx Biosciences Inc?

First you should know what it really means to hold a share of Ventyx Biosciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Ventyx Biosciences Inc is $4.47. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ventyx Biosciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ventyx Biosciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $3.46. Based on the TTM, the Book Value Change Per Share is $-0.39 per quarter. Based on the YOY, the Book Value Change Per Share is $0.27 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ventyx Biosciences Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.66-14.9%-0.68-15.3%-0.38-8.6%-0.45-10.1%-0.45-10.1%
Usd Book Value Change Per Share-0.56-12.6%-0.39-8.7%0.275.9%0.276.0%0.276.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.56-12.6%-0.39-8.7%0.275.9%0.276.0%0.276.0%
Usd Price Per Share2.47-25.88-23.38-16.68-16.68-
Price to Earnings Ratio-0.93--9.56--14.46--8.90--8.90-
Price-to-Total Gains Ratio-4.38-5.16--40.48--15.28--15.28-
Price to Book Ratio0.71-5.68-5.04-3.69-3.69-
Price-to-Total Gains Ratio-4.38-5.16--40.48--15.28--15.28-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.47
Number of shares223
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.390.27
Usd Total Gains Per Share-0.390.27
Gains per Quarter (223 shares)-87.0559.41
Gains per Year (223 shares)-348.22237.65
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-348-3580238228
20-696-7060475466
30-1045-10540713704
40-1393-14020951942
50-1741-1750011881180
60-2089-2098014261418
70-2438-2446016641656
80-2786-2794019011894
90-3134-3142021392132
100-3482-3490023772370

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.013.00.00.0%0.013.00.00.0%0.013.00.00.0%
Book Value Change Per Share1.03.00.025.0%3.08.01.025.0%3.09.01.023.1%3.09.01.023.1%3.09.01.023.1%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.013.00.0%0.00.013.00.0%0.00.013.00.0%
Total Gains per Share1.03.00.025.0%3.08.01.025.0%3.09.01.023.1%3.09.01.023.1%3.09.01.023.1%

Fundamentals of Ventyx Biosciences Inc

About Ventyx Biosciences Inc

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates to address a range of inflammatory diseases. The company's lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn's disease. It is also developing VTX002, a sphingosine 1 phosphate receptor modulator that is in Phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 inflammasome inhibitor to treat patients with cryopyrin-associated periodic syndrome. In addition, the company develops VTX3232, a CNS-penetrant NLRP3 inhibitor. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in San Diego, California.

Fundamental data was last updated by Penke on 2024-03-31 13:43:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Ventyx Biosciences Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Ventyx Biosciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Ventyx Biosciences Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Ventyx Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--199.6%+199.6%
TTM--213.0%+213.0%
YOY--279.3%+279.3%
5Y--438.4%+438.4%
10Y--605.5%+605.5%
1.1.2. Return on Assets

Shows how efficient Ventyx Biosciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Ventyx Biosciences Inc to the Biotechnology industry mean.
  • -16.8% Return on Assets means that Ventyx Biosciences Inc generated $-0.17 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Ventyx Biosciences Inc:

  • The MRQ is -16.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -14.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-16.8%TTM-14.5%-2.3%
TTM-14.5%YOY-8.0%-6.5%
TTM-14.5%5Y-1,715.5%+1,701.0%
5Y-1,715.5%10Y-1,715.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-16.8%-13.5%-3.3%
TTM-14.5%-12.9%-1.6%
YOY-8.0%-11.8%+3.8%
5Y-1,715.5%-14.1%-1,701.4%
10Y-1,715.5%-16.0%-1,699.5%
1.1.3. Return on Equity

Shows how efficient Ventyx Biosciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Ventyx Biosciences Inc to the Biotechnology industry mean.
  • -19.2% Return on Equity means Ventyx Biosciences Inc generated $-0.19 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Ventyx Biosciences Inc:

  • The MRQ is -19.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -13.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-19.2%TTM-13.6%-5.6%
TTM-13.6%YOY-6.1%-7.5%
TTM-13.6%5Y-6.6%-7.0%
5Y-6.6%10Y-6.6%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-19.2%-16.9%-2.3%
TTM-13.6%-16.1%+2.5%
YOY-6.1%-15.1%+9.0%
5Y-6.6%-19.9%+13.3%
10Y-6.6%-20.9%+14.3%

1.2. Operating Efficiency of Ventyx Biosciences Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Ventyx Biosciences Inc is operating .

  • Measures how much profit Ventyx Biosciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Ventyx Biosciences Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Ventyx Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--295.1%+295.1%
TTM--225.8%+225.8%
YOY--288.4%+288.4%
5Y--477.4%+477.4%
10Y--625.6%+625.6%
1.2.2. Operating Ratio

Measures how efficient Ventyx Biosciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Ventyx Biosciences Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.090-3.090
TTM-3.264-3.264
YOY-3.783-3.783
5Y-5.679-5.679
10Y-7.894-7.894

1.3. Liquidity of Ventyx Biosciences Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Ventyx Biosciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 11.87 means the company has $11.87 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Ventyx Biosciences Inc:

  • The MRQ is 11.873. The company is very able to pay all its short-term debts. +2
  • The TTM is 16.093. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ11.873TTM16.093-4.220
TTM16.093YOY15.172+0.920
TTM16.0935Y14.233+1.859
5Y14.23310Y14.2330.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.8733.914+7.959
TTM16.0934.220+11.873
YOY15.1725.388+9.784
5Y14.2336.045+8.188
10Y14.2336.406+7.827
1.3.2. Quick Ratio

Measures if Ventyx Biosciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Ventyx Biosciences Inc to the Biotechnology industry mean.
  • A Quick Ratio of 20.38 means the company can pay off $20.38 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Ventyx Biosciences Inc:

  • The MRQ is 20.376. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 28.388. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ20.376TTM28.388-8.012
TTM28.388YOY26.265+2.123
TTM28.3885Y22.024+6.364
5Y22.02410Y22.0240.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ20.3763.572+16.804
TTM28.3883.998+24.390
YOY26.2655.390+20.875
5Y22.0245.969+16.055
10Y22.0246.287+15.737

1.4. Solvency of Ventyx Biosciences Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Ventyx Biosciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Ventyx Biosciences Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.12 means that Ventyx Biosciences Inc assets are financed with 12.2% credit (debt) and the remaining percentage (100% - 12.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Ventyx Biosciences Inc:

  • The MRQ is 0.122. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.086. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.122TTM0.086+0.035
TTM0.086YOY0.069+0.017
TTM0.0865Y19.708-19.622
5Y19.70810Y19.7080.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1220.336-0.214
TTM0.0860.334-0.248
YOY0.0690.269-0.200
5Y19.7080.366+19.342
10Y19.7080.390+19.318
1.4.2. Debt to Equity Ratio

Measures if Ventyx Biosciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Ventyx Biosciences Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 13.8% means that company has $0.14 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Ventyx Biosciences Inc:

  • The MRQ is 0.138. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.084. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.138TTM0.084+0.054
TTM0.084YOY0.062+0.022
TTM0.0845Y0.048+0.036
5Y0.04810Y0.0480.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1380.382-0.244
TTM0.0840.396-0.312
YOY0.0620.335-0.273
5Y0.0480.434-0.386
10Y0.0480.465-0.417

2. Market Valuation of Ventyx Biosciences Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Ventyx Biosciences Inc generates.

  • Above 15 is considered overpriced but always compare Ventyx Biosciences Inc to the Biotechnology industry mean.
  • A PE ratio of -0.93 means the investor is paying $-0.93 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Ventyx Biosciences Inc:

  • The EOD is -1.683. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.930. Based on the earnings, the company is expensive. -2
  • The TTM is -9.561. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.683MRQ-0.930-0.753
MRQ-0.930TTM-9.561+8.631
TTM-9.561YOY-14.460+4.899
TTM-9.5615Y-8.905-0.656
5Y-8.90510Y-8.9050.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.683-2.259+0.576
MRQ-0.930-2.569+1.639
TTM-9.561-2.664-6.897
YOY-14.460-4.120-10.340
5Y-8.905-6.258-2.647
10Y-8.905-6.171-2.734
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Ventyx Biosciences Inc:

  • The EOD is -1.517. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.838. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -12.291. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.517MRQ-0.838-0.679
MRQ-0.838TTM-12.291+11.453
TTM-12.291YOY-17.738+5.447
TTM-12.2915Y-11.064-1.227
5Y-11.06410Y-11.0640.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.517-2.924+1.407
MRQ-0.838-3.246+2.408
TTM-12.291-3.488-8.803
YOY-17.738-5.620-12.118
5Y-11.064-8.315-2.749
10Y-11.064-8.826-2.238
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Ventyx Biosciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.71 means the investor is paying $0.71 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Ventyx Biosciences Inc:

  • The EOD is 1.291. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.713. Based on the equity, the company is cheap. +2
  • The TTM is 5.683. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD1.291MRQ0.713+0.577
MRQ0.713TTM5.683-4.970
TTM5.683YOY5.042+0.641
TTM5.6835Y3.685+1.998
5Y3.68510Y3.6850.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.2911.851-0.560
MRQ0.7132.090-1.377
TTM5.6832.095+3.588
YOY5.0422.844+2.198
5Y3.6853.466+0.219
10Y3.6853.815-0.130
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Ventyx Biosciences Inc.

3.1. Institutions holding Ventyx Biosciences Inc

Institutions are holding 84.455% of the shares of Ventyx Biosciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31BlackRock Inc6.43920.000238145311863115.1351
2023-12-31Vanguard Group Inc6.31660.00023741925107925440.5328
2023-09-30Citadel Advisors Llc4.96210.021929394811523495.4662
2023-12-31Goldman Sachs Group Inc4.6010.00062725578111003268.7094
2023-12-31Capital Research & Mgmt Co - Division 33.9740.00132354149-373703-13.6995
2023-12-31Logos Global Management LP3.37610.461120000001775000788.8889
2023-12-31Millennium Management LLC3.26570.0021193454618757863192.2839
2023-12-31Morgan Stanley - Brokerage Accounts3.23270.000419150261630919574.051
2023-09-30Holocene Advisors, LP2.69870.24311598691616074.008
2023-09-30Point72 Asset Management, L.P.2.1920.1316129849349949362.5148
2023-12-31Opaleye Management Inc1.92440.7488114000011400000
2023-12-31Two Sigma Investments LLC1.90510.0064112853810831382385.7665
2023-12-31Two Sigma Advisers, LLC1.87220.0064110910011091000
2023-12-31Geode Capital Management, LLC1.73130.00031025619498095.1044
2023-12-31State Street Corporation1.67190.0001990423-106096-9.6757
2023-12-31Qube Research & Technologies1.58940.00459415569415560
2023-09-30Redmile Group, LLC1.56971.5366929900-10593-1.1263
2023-12-31TCG Crossover Management, LLC1.3770.223581572400
2023-12-31Bridgeway Capital Management, LLC1.19990.03777108007108000
2023-12-31Qiming U.S. Ventures Management, LLC1.15861.552468637000
Total 57.05764.979233800450+12914762+38.2%

3.2. Funds holding Ventyx Biosciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31American Funds SMALLCAP World A3.9740.00812354149-373703-13.6995
2024-02-29Vanguard Total Stock Mkt Idx Inv2.34720.00061390461-217900-13.548
2024-02-29iShares Russell 2000 ETF1.91310.01291133277-185-0.0163
2023-12-31Bridgeway Ultra-Small Company1.19992.02557108007108000
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.17390.0048695410184702.7285
2023-12-31Vanguard VIF Small Co Gr0.86540.08375126605126600
2023-10-31Pictet-Biotech P USD0.8560.572507115-9303-1.8014
2023-12-31Fidelity Small Cap Index0.77050.004445641400
2023-12-31American Century U.S. Small Cap Growth0.74120.033943910721181693.1915
2023-12-31American Century Small Cap Growth Inv0.74120.033843910721181693.1915
2024-02-29iShares Russell 2000 Growth ETF0.69150.0256409666-476-0.1161
2024-02-29iShares Biotechnology ETF0.60120.0332356123-1605-0.4487
2023-09-30FIAM Small Cap Core Composite0.59080.347835000000
2023-10-31Pictet-Global Megatrend Sel I USD0.58280.04683452275540.1607
2023-12-31Vanguard Strategic Small-Cap Equity Inv0.5150.05063050703050700
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.47050.004727872249001.7895
2024-01-31Fidelity Extended Market Index0.43990.001526057300
2024-02-29Schwab US Small-Cap ETF™0.37120.010421986600
2023-06-30Small Mid Cap Growth CIT C0.35030.75392075052075050
2024-02-29Vanguard Russell 2000 ETF0.28740.0126170258131768.388
Total 19.4834.066811541510+1593595+13.8%

3.3. Insider Transactions

Insiders are holding 3.172% of the shares of Ventyx Biosciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-12-20John NussSELL176282.12
2023-12-20Raju MohanSELL588602.12
2023-10-09Nsv Partners Iii LpSELL4915230.03
2023-10-05Raju MohanSELL3000029.11
2023-10-03Christopher W KruegerSELL1500029.98
2023-09-18Somu SubramaniamSELL5666537.81
2023-08-31William J SandbornSELL1190033.64
2023-08-08William J SandbornSELL349432.86
2023-08-07Raju MohanSELL3000033.52
2023-08-03John NussSELL1000035.6
2023-07-31Somu SubramaniamSELL1080337.59
2023-07-31William J SandbornSELL1190037.16
2023-07-28Somu SubramaniamSELL61137.53
2023-07-25Martin AusterSELL2800035.54
2023-07-12Somu SubramaniamSELL327537.62
2023-07-11Nsv Partners Iii LpSELL2864637.54
2023-07-07Somu SubramaniamSELL10000035.23
2023-07-05Raju MohanSELL3000038.37
2023-07-03John NussSELL2000039.58
2023-07-03Nsv Partners Iii LpSELL13408039

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Ventyx Biosciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.564-0.390-31%0.265-313%0.266-312%0.266-312%
Book Value Per Share--3.4644.356-20%4.401-21%2.754+26%2.754+26%
Current Ratio--11.87316.093-26%15.172-22%14.233-17%14.233-17%
Debt To Asset Ratio--0.1220.086+41%0.069+77%19.708-99%19.708-99%
Debt To Equity Ratio--0.1380.084+65%0.062+124%0.048+187%0.048+187%
Dividend Per Share----0%-0%-0%-0%
Eps---0.664-0.685+3%-0.385-42%-0.454-32%-0.454-32%
Free Cash Flow Per Share---0.736-0.593-19%-0.352-52%-0.335-54%-0.335-54%
Free Cash Flow To Equity Per Share---0.728-0.404-45%0.244-398%0.262-378%0.262-378%
Gross Profit Margin--1.0191.005+1%1.000+2%1.001+2%1.001+2%
Intrinsic Value_10Y_max---52.273--------
Intrinsic Value_10Y_min---43.910--------
Intrinsic Value_1Y_max---1.996--------
Intrinsic Value_1Y_min---1.958--------
Intrinsic Value_3Y_max---8.467--------
Intrinsic Value_3Y_min---8.034--------
Intrinsic Value_5Y_max---17.918--------
Intrinsic Value_5Y_min---16.418--------
Market Cap314806008.000+45%173953208.0001822283100.000-90%1646217100.000-89%1174820700.308-85%1174820700.308-85%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio1.291+45%0.7135.683-87%5.042-86%3.685-81%3.685-81%
Pe Ratio-1.683-81%-0.930-9.561+928%-14.460+1455%-8.905+857%-8.905+857%
Price Per Share4.470+45%2.47025.875-90%23.375-89%16.682-85%16.682-85%
Price To Free Cash Flow Ratio-1.517-81%-0.838-12.291+1366%-17.738+2016%-11.064+1220%-11.064+1220%
Price To Total Gains Ratio-7.926-81%-4.3805.159-185%-40.484+824%-15.276+249%-15.276+249%
Quick Ratio--20.37628.388-28%26.265-22%22.024-7%22.024-7%
Return On Assets---0.168-0.145-14%-0.080-52%-17.155+10090%-17.155+10090%
Return On Equity---0.192-0.136-29%-0.061-68%-0.066-66%-0.066-66%
Total Gains Per Share---0.564-0.390-31%0.265-313%0.266-312%0.266-312%
Usd Book Value--243923000.000306747000.000-20%309925750.000-21%193930538.462+26%193930538.462+26%
Usd Book Value Change Per Share---0.564-0.390-31%0.265-313%0.266-312%0.266-312%
Usd Book Value Per Share--3.4644.356-20%4.401-21%2.754+26%2.754+26%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.664-0.685+3%-0.385-42%-0.454-32%-0.454-32%
Usd Free Cash Flow---51866000.000-41759000.000-19%-24761500.000-52%-23606307.692-54%-23606307.692-54%
Usd Free Cash Flow Per Share---0.736-0.593-19%-0.352-52%-0.335-54%-0.335-54%
Usd Free Cash Flow To Equity Per Share---0.728-0.404-45%0.244-398%0.262-378%0.262-378%
Usd Market Cap314806008.000+45%173953208.0001822283100.000-90%1646217100.000-89%1174820700.308-85%1174820700.308-85%
Usd Price Per Share4.470+45%2.47025.875-90%23.375-89%16.682-85%16.682-85%
Usd Profit---46753000.000-47335250.000+1%-26730750.000-43%-30516307.692-35%-30516307.692-35%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.564-0.390-31%0.265-313%0.266-312%0.266-312%
 EOD+5 -3MRQTTM+6 -24YOY+4 -265Y+9 -2110Y+9 -21

4.2. Fundamental Score

Let's check the fundamental score of Ventyx Biosciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.683
Price to Book Ratio (EOD)Between0-11.291
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than120.376
Current Ratio (MRQ)Greater than111.873
Debt to Asset Ratio (MRQ)Less than10.122
Debt to Equity Ratio (MRQ)Less than10.138
Return on Equity (MRQ)Greater than0.15-0.192
Return on Assets (MRQ)Greater than0.05-0.168
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Ventyx Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.406
Ma 20Greater thanMa 505.125
Ma 50Greater thanMa 1005.858
Ma 100Greater thanMa 2004.052
OpenGreater thanClose4.330
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets277,693
Total Liabilities33,770
Total Stockholder Equity243,923
 As reported
Total Liabilities 33,770
Total Stockholder Equity+ 243,923
Total Assets = 277,693

Assets

Total Assets277,693
Total Current Assets264,345
Long-term Assets13,348
Total Current Assets
Cash And Cash Equivalents 51,579
Short-term Investments 200,641
Net Receivables 800
Inventory -800
Other Current Assets 12,125
Total Current Assets  (as reported)264,345
Total Current Assets  (calculated)264,345
+/-0
Long-term Assets
Property Plant Equipment 12,271
Long-term Assets Other 1,077
Long-term Assets  (as reported)13,348
Long-term Assets  (calculated)13,348
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities22,265
Long-term Liabilities11,505
Total Stockholder Equity243,923
Total Current Liabilities
Short-term Debt 1,001
Accounts payable 5,756
Other Current Liabilities 15,508
Total Current Liabilities  (as reported)22,265
Total Current Liabilities  (calculated)22,265
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt11,505
Long-term Liabilities  (as reported)11,505
Long-term Liabilities  (calculated)11,505
+/-0
Total Stockholder Equity
Common Stock6
Retained Earnings -419,187
Accumulated Other Comprehensive Income -50
Other Stockholders Equity 663,154
Total Stockholder Equity (as reported)243,923
Total Stockholder Equity (calculated)243,923
+/-0
Other
Capital Stock6
Cash and Short Term Investments 252,220
Common Stock Shares Outstanding 59,076
Liabilities and Stockholders Equity 277,693
Net Debt -39,073
Net Invested Capital 243,923
Net Working Capital 242,080
Property Plant and Equipment Gross 12,530
Short Long Term Debt Total 12,506



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-03-31
> Total Assets 
0
0
245
0
105,916
148,709
291,482
277,953
262,185
420,445
371,400
389,169
348,763
321,701
277,693
277,693321,701348,763389,169371,400420,445262,185277,953291,482148,709105,916024500
   > Total Current Assets 
0
0
245
105,028
105,028
145,659
263,020
257,505
252,193
418,390
330,688
387,051
346,701
308,092
264,345
264,345308,092346,701387,051330,688418,390252,193257,505263,020145,659105,028105,02824500
       Cash And Cash Equivalents 
0
0
244
0
102,788
68,986
70,791
41,690
45,343
263,270
64,819
63,669
51,717
56,610
51,579
51,57956,61051,71763,66964,819263,27045,34341,69070,79168,986102,788024400
       Short-term Investments 
0
0
0
0
0
72,966
187,785
212,656
205,109
149,153
253,122
313,246
280,535
244,209
200,641
200,641244,209280,535313,246253,122149,153205,109212,656187,78572,96600000
       Net Receivables 
0
0
0
0
0
2,831
60
60
72
72
96
49
0
0
800
800004996727260602,83100000
       Other Current Assets 
0
0
1
0
2,240
3,707
4,444
3,159
1,741
5,967
12,747
10,087
14,449
7,273
12,125
12,1257,27314,44910,08712,7475,9671,7413,1594,4443,7072,2400100
   > Long-term Assets 
0
0
0
0
888
3,050
28,462
20,448
9,992
2,055
40,712
2,118
2,062
13,609
13,348
13,34813,6092,0622,11840,7122,0559,99220,44828,4623,0508880000
       Property Plant Equipment 
0
0
0
72
72
219
254
1,587
2,020
1,983
1,944
2,022
1,960
12,532
12,271
12,27112,5321,9602,0221,9441,9832,0201,5872542197272000
       Long Term Investments 
0
0
0
0
0
0
28,148
18,801
7,900
0
38,672
0
0
0
0
000038,67207,90018,80128,148000000
       Other Assets 
0
0
0
816
816
2,831
60
60
72
72
96
0
0
0
0
000096727260602,831816816000
> Total Liabilities 
0
0
30,899
0
181,780
236,330
12,283
18,830
19,033
36,912
17,505
17,551
20,956
38,061
33,770
33,77038,06120,95617,55117,50536,91219,03318,83012,283236,330181,780030,89900
   > Total Current Liabilities 
0
0
1,403
8,064
8,064
11,809
12,283
17,791
17,674
35,661
16,359
16,515
20,034
26,208
22,265
22,26526,20820,03416,51516,35935,66117,67417,79112,28311,8098,0648,0641,40300
       Short-term Debt 
0
0
0
0
0
0
0
278
386
395
412
426
439
479
1,001
1,0014794394264123953862780000000
       Accounts payable 
0
0
1,102
2,373
2,373
4,263
4,661
7,114
5,805
18,582
6,433
6,552
4,085
9,338
5,756
5,7569,3384,0856,5526,43318,5825,8057,1144,6614,2632,3732,3731,10200
       Other Current Liabilities 
0
0
301
0
5,691
7,546
7,622
10,399
11,483
16,684
9,514
9,537
15,510
16,391
15,508
15,50816,39115,5109,5379,51416,68411,48310,3997,6227,5465,691030100
   > Long-term Liabilities 
0
0
29,496
0
173,716
224,521
4,661
1,039
1,359
1,251
1,146
1,036
922
11,853
11,505
11,50511,8539221,0361,1461,2511,3591,0394,661224,521173,716029,49600
       Warrants
0
0
0
0
0
224,521
0
0
0
0
0
0
0
0
0
000000000224,52100000
       Deferred Long Term Liability 
0
0
0
753
753
2,768
0
0
0
0
0
0
0
0
0
0000000002,768753753000
> Total Stockholder Equity
0
0
-30,654
0
-75,864
-87,621
279,199
259,123
243,152
383,533
-226,225
-265,156
327,807
283,640
243,923
243,923283,640327,807-265,156-226,225383,533243,152259,123279,199-87,621-75,8640-30,65400
   Common Stock
0
0
0
4
4
-148,709
5
5
5
6
6
6
6
6
6
666666555-148,70944000
   Retained Earnings Total Equity000-265,156-226,225-191,011-160,549-140,531-117,799-100,03100000
   Accumulated Other Comprehensive Income 
0
0
0
0
-12
17
-58
-958
-1,291
-1,312
-1,123
-561
-710
-507
-50
-50-507-710-561-1,123-1,312-1,291-958-5817-120000
   Capital Surplus 
0
0
0
0
0
12,393
397,051
400,607
404,987
575,850
581,237
637,329
0
0
0
000637,329581,237575,850404,987400,607397,05112,39300000
   Treasury Stock000000000000000
   Other Stockholders Equity 
0
0
1,847
-12
11,405
12,393
397,051
400,607
404,987
575,850
1,117
555
646,918
656,575
663,154
663,154656,575646,9185551,117575,850404,987400,607397,05112,39311,405-121,84700



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-941
Gross Profit-941-941
 
Operating Income (+$)
Gross Profit-941
Operating Expense-204,553
Operating Income-205,494-205,494
 
Operating Expense (+$)
Research Development173,867
Selling General Administrative32,227
Selling And Marketing Expenses1,541
Operating Expense204,553207,635
 
Net Interest Income (+$)
Interest Income14,638
Interest Expense-0
Other Finance Cost-0
Net Interest Income14,638
 
Pretax Income (+$)
Operating Income-205,494
Net Interest Income14,638
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-192,962-218,026
EBIT - interestExpense = -205,494
-192,962
-192,962
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-205,494-192,962
Earnings Before Interest and Taxes (EBITDA)-204,553
 
After tax Income (+$)
Income Before Tax-192,962
Tax Provision-0
Net Income From Continuing Ops-181,423-192,962
Net Income-192,962
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses205,494
Total Other Income/Expenses Net12,532-14,638
 

Technical Analysis of Ventyx Biosciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Ventyx Biosciences Inc. The general trend of Ventyx Biosciences Inc is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Ventyx Biosciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Ventyx Biosciences Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 6.82 < 11.07 < 11.48.

The bearish price targets are: 2.81 > 1.865.

Tweet this
Ventyx Biosciences Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Ventyx Biosciences Inc. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Ventyx Biosciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Ventyx Biosciences Inc. The current macd is -0.51861814.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Ventyx Biosciences Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Ventyx Biosciences Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Ventyx Biosciences Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Ventyx Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartVentyx Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Ventyx Biosciences Inc. The current adx is 24.37.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Ventyx Biosciences Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Ventyx Biosciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Ventyx Biosciences Inc. The current sar is 4.7683.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Ventyx Biosciences Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Ventyx Biosciences Inc. The current rsi is 36.41. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Ventyx Biosciences Inc Daily Relative Strength Index (RSI) ChartVentyx Biosciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Ventyx Biosciences Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Ventyx Biosciences Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Ventyx Biosciences Inc Daily Stochastic Oscillator ChartVentyx Biosciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Ventyx Biosciences Inc. The current cci is -84.05216144.

Ventyx Biosciences Inc Daily Commodity Channel Index (CCI) ChartVentyx Biosciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Ventyx Biosciences Inc. The current cmo is -37.02168853.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Ventyx Biosciences Inc Daily Chande Momentum Oscillator (CMO) ChartVentyx Biosciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Ventyx Biosciences Inc. The current willr is -81.92307692.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Ventyx Biosciences Inc Daily Williams %R ChartVentyx Biosciences Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Ventyx Biosciences Inc.

Ventyx Biosciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Ventyx Biosciences Inc. The current atr is 0.50822148.

Ventyx Biosciences Inc Daily Average True Range (ATR) ChartVentyx Biosciences Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Ventyx Biosciences Inc. The current obv is 65,960,143.

Ventyx Biosciences Inc Daily On-Balance Volume (OBV) ChartVentyx Biosciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Ventyx Biosciences Inc. The current mfi is 27.85.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Ventyx Biosciences Inc Daily Money Flow Index (MFI) ChartVentyx Biosciences Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Ventyx Biosciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-02RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-30MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-31MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-22ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

Ventyx Biosciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Ventyx Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.406
Ma 20Greater thanMa 505.125
Ma 50Greater thanMa 1005.858
Ma 100Greater thanMa 2004.052
OpenGreater thanClose4.330
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Ventyx Biosciences Inc with someone you think should read this too:
  • Are you bullish or bearish on Ventyx Biosciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Ventyx Biosciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Ventyx Biosciences Inc

I send you an email if I find something interesting about Ventyx Biosciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Ventyx Biosciences Inc.

Receive notifications about Ventyx Biosciences Inc in your mailbox!